Acrivon draws in $130M; Vincerx Pharma's Ph1 metastatic tumor data
Acrivon raises $130M PIPE: The precision oncology biotech brought in the money from RA Capital, Perceptive Advisors and other investors. Its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
